Todd Asset Management LLC raised its stake in Allergan PLC. (NYSE:AGN) by 5.8% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 118,727 shares of the company’s stock after buying an additional 6,504 shares during the quarter. Todd Asset Management LLC’s holdings in Allergan PLC. were worth $28,861,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of AGN. Veritas Asset Management LLP bought a new stake in Allergan PLC. in the first quarter valued at $761,339,000. Iridian Asset Management LLC CT raised its stake in shares of Allergan PLC. by 141.3% during the first quarter. Iridian Asset Management LLC CT now owns 1,283,833 shares of the company’s stock valued at $306,733,000 after purchasing an additional 751,848 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Allergan PLC. during the first quarter valued at about $124,255,000. Blue Ridge Capital L.L.C. raised its stake in shares of Allergan PLC. by 24.1% during the first quarter. Blue Ridge Capital L.L.C. now owns 1,909,900 shares of the company’s stock valued at $456,313,000 after purchasing an additional 370,400 shares in the last quarter. Finally, Harbour Capital Advisors LLC raised its stake in shares of Allergan PLC. by 21,412.3% during the second quarter. Harbour Capital Advisors LLC now owns 345,917 shares of the company’s stock valued at $1,423,000 after purchasing an additional 344,309 shares in the last quarter. Institutional investors own 82.02% of the company’s stock.
A number of equities research analysts recently weighed in on AGN shares. Sanford C. Bernstein restated an “outperform” rating on shares of Allergan PLC. in a research note on Thursday, May 25th. ValuEngine cut shares of Allergan PLC. from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Cowen and Company set a $400.00 price objective on shares of Allergan PLC. and gave the company a “buy” rating in a research note on Thursday, June 8th. Mizuho cut their price objective on shares of Allergan PLC. from $275.00 to $267.00 and set a “buy” rating on the stock in a research note on Friday, June 9th. Finally, Royal Bank Of Canada set a $284.00 price objective on shares of Allergan PLC. and gave the company a “buy” rating in a research note on Monday, June 12th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company’s stock. Allergan PLC. presently has a consensus rating of “Buy” and an average target price of $273.34.
Allergan PLC. (AGN) opened at 210.00 on Thursday. The company has a 50-day moving average price of $229.79 and a 200-day moving average price of $236.07. Allergan PLC. has a 52 week low of $184.50 and a 52 week high of $256.80. The stock has a market cap of $70.20 billion, a PE ratio of 6.40 and a beta of 1.18.
Allergan PLC. (NYSE:AGN) last released its earnings results on Thursday, August 3rd. The company reported $4.02 earnings per share for the quarter, beating the consensus estimate of $3.95 by $0.07. Allergan PLC. had a return on equity of 7.37% and a net margin of 79.17%. The firm had revenue of $4.01 billion for the quarter, compared to analyst estimates of $3.95 billion. During the same quarter in the prior year, the firm posted $3.35 earnings per share. The company’s quarterly revenue was up 8.8% on a year-over-year basis. Analysts anticipate that Allergan PLC. will post $16.25 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, September 15th. Shareholders of record on Friday, August 18th were paid a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.33%. The ex-dividend date was Wednesday, August 16th. Allergan PLC.’s payout ratio is 9.95%.
TRADEMARK VIOLATION WARNING: This report was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/09/21/todd-asset-management-llc-buys-6504-shares-of-allergan-plc-agn.html.
Allergan PLC. Company Profile
Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.
Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with MarketBeat.com's FREE daily email newsletter.